Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography
A Multicenter, Controlled Clinical Trial to Evaluate the Hologic 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography
Sponsor: Hologic, Inc.
Listed as NCT00754598, this NA trial focuses on Breast Cancer and remains completed. Sponsored by Hologic, Inc., it has been updated 10 times since 2006, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Withheld → Completed · Phase: None → NA
-
Jul 2022 — Sep 2022 [monthly]
Withheld
-
Dec 2021 — Jul 2022 [monthly]
Withheld
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Withheld
-
Jun 2018 — Jan 2021 [monthly]
Withheld
-
Apr 2018 — Jun 2018 [monthly]
Withheld
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hologic, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .